TheStreet home
TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Health

3D Systems Dives After Big Top-Line and Bottom-Line Misses
INVESTING

3D Systems, CollPlant Rise on Plan for Breast-Reconstruction Solutions

Biocept Lead
INVESTING

Biocept Jumps on Quest Accord to Offer Lung Cancer Testing

Medicinova Lead
INVESTING

Medicinova Jumps on Phase 2 Progress With Alcohol-Abuse Drug

Vaccine Lead
INVESTING

COVID in Pets, Comparing Vaccines and Why the U.S. Isn't in the Clear

Covid-19 Vaccine Lead
HEALTH

U.S. 'Not Out of the Woods Yet' With COVID Pandemic, Say Experts

Nano-X Lead
INVESTING

Nanox Higher on Application to FDA for Medical Imaging System

23andMe Lead
INVESTING

23andMe Genetic-Testing Firm Opens at $11.13 After Going Public Via SPAC

Jim Cramer Looks for Growth in Comcast, Southwest and Danaher
INVESTING

Danaher to Purchase Biotech Aldevron in $9.6 Billion Deal

Biotech Lead
INVESTING

Midatech Pharma Soars on Drug Delivery Technology 'Breakthrough'

Royal Caribbean Reports Mixed Quarterly Results
INVESTING

Royal Caribbean Delays Cruise After 8 Crew Test COVID Positive

Centene Corporation Lead
INVESTING

Centene Rises After Affirming Earnings Guidance

Newly Public Elanco Seeks to Innovate With Offering Proceeds
INVESTING

Kindred Biosciences Jumps on $440 Million Deal to Merge With Elanco Animal Health

Ocugen Lead
INVESTING

Ocugen Jumps After Choosing Partner to Make COVID-19 Vaccine

Sage Therapeutics Lifts Investor Spirits With Sliver of Depression Drug Data
INVESTING

Sage Therapeutics Plunges After Depression Drug-Trial Results

ResMed: Cramer's Top Takeaways
INVESTING

ResMed Rises as Royal Philips Recalls Sleep Apnea Devices

6. Centene Corp. (CNC)
INVESTING

Centene Eases After Settling Medicaid Lawsuit With Ohio, Mississippi

Crypto Risks Swell as Lack of Regulation Opens Door for Market Manipulation
Video

Crypto-Share Rally, Curis and Novavax – On TheStreet Monday

Chinese Prostate, Breast Cancer Drugs Maker Kintor's IPO More Than 500 Times Oversubscribed As Hong Kong Biotech Investment Fever Continues
INVESTING

Curis Shares Stabilize After Rout as Analysts Reiterate Price Targets

Vaccine Lead
HEALTH

Pfizer, Moderna Vaccine Risk to Teens 'Tiny,' Says UCLA Heart Doc

No More Tears for Johnson & Johnson?
STOCKS

FDA Reveals Details of Problems at Third-Party Maker of JNJ Shot

Novan Only Piercing the Skin of Its Potential Says CEO
INVESTING

Novan Jumps as Skin Treatment Progresses in Phase 3 Trial

Vertex Pharmaceuticals to Rely on Acquisitions to Diversify Its Business
INVESTING

Vertex Pharmaceuticals Seen as Buying Opportunity as Stock Plunges

Vertex Pharma Jumps 14% After Rival Releases Poor Cystic Fibrosis Drug Results
INVESTING

Vertex Halts Further Study of AATD Drug

Why Bristol-Myers Squibb May Be a Merger Target Soon
INVESTING

Bristol-Myers Higher on Progress With Lymphoma-Drug Trial